未经证实:本研究旨在探讨我们的理性情绪行为疗法(REBT)计划对症状的影响,焦虑,抑郁症,接受化疗的结直肠癌(CRC)患者的睡眠状态。
UNASSIGNED:选择2020年10月至2021年5月湖南省某医院56例CRC患者,随机分为干预组(28例)和对照组(28例)。干预组患者在常规护理基础上完成为期6周的REBT方案,包括4个课程:1)建立关系,制定健康档案;2)团体沟通,研究症状管理;3)持续提供健康知识,加强健康行为;4)回顾治疗和总结。对照组保持常规护理。简体中文版纪念症状评估量表简表(MSAS-SF-SC),医院焦虑和抑郁量表(HADS),采用匹兹堡睡眠质量指数(PSQI)量表对两组患者基线时(T1、干预前)的干预效果进行调查比较,四周(T2),干预后6周(T3)。
UNASSIGNED:干预组症状明显改善,焦虑,抑郁症,和睡眠状态,与对照组相比。在T2时,MSAS-SF-SC(24.43±4.26vs.28.07±3.91),症状困扰(17.29±4.04vs.19.39±3.59),症状频率(7.14±1.51vs.8.68±1.42),HADS(13.68±3.38vs.15.86±3.79),焦虑(3.89±1.85vs.5.18±2.18),和抑郁(9.79±2.06vs.10.68±2.23),两组比较差异有统计学意义(P<0.05)。T3时,MSAS-SF-SC(23.89±3.54vs.30.14±3.94),症状困扰(17.61±3.52vs.21.32±3.57),症状频率(6.29±1.49vs.8.82±1.47),HADS(11.82±2.57vs.16.29±3.13),焦虑(3.21±1.64vs.5.61±1.77),和抑郁症(8.61±1.52vs.10.68±1.81),两组比较差异有统计学意义(P<0.05)。T3时干预组睡眠状态优于对照组,PSQI评分降低[4.00(3.00,8.00)vs.9.00(7.00,12.50),Z=-3.706,P<0.001]。
UNASSIGNED:为期6周的REBT计划可有效改善症状,焦虑,抑郁症,接受化疗的CRC患者的睡眠状态,这可以作为反复入院接受化疗的CRC患者的护理计划。
UNASSIGNED: This study aimed to explore the effects of our rational emotive behavior therapy (REBT) program on symptoms, anxiety, depression, and sleep state in patients with colorectal cancer (CRC) undergoing chemotherapy.
UNASSIGNED: From October 2020 to May 2021, fifty-six patients with CRC in a hospital in the Hunan Province were randomly divided into an intervention group (n = 28) and a control group (n = 28). The patients in the intervention group completed a 6-week REBT program based on routine nursing care, including four courses: 1) establish a relationship and formulate health files; 2) group communications and study symptom management; 3) continuously provide health knowledge and strengthen healthy behavior; and 4) review the treatment and summary. The control group maintained routine nursing care. The simplified Chinese version of the Memorial Symptom Assessment Scale Short Form (MSAS-SF-SC), the Hospital Anxiety and Depression Scale (HADS), and the Pittsburgh Sleep Quality Index (PSQI) scale were used to investigate and compare the intervention effects of the two groups at baseline (T1, before the intervention), four weeks (T2), and six weeks (T3) after the intervention.
UNASSIGNED: The intervention group was significantly improved in symptoms, anxiety, depression, and sleep state, compared with the control group. At T2, MSAS-SF-SC (24.43 ± 4.26 vs.28.07 ± 3.91), symptom distress (17.29 ± 4.04 vs. 19.39 ± 3.59), symptom frequency (7.14 ± 1.51 vs. 8.68 ± 1.42), HADS (13.68 ± 3.38 vs. 15.86 ± 3.79), anxiety (3.89 ± 1.85 vs. 5.18 ± 2.18), and depression (9.79 ± 2.06 vs. 10.68 ± 2.23), showed that the difference between the two groups was statistically significant (P < 0.05). At T3, MSAS-SF-SC (23.89 ± 3.54 vs. 30.14 ± 3.94), symptom distress (17.61 ± 3.52 vs. 21.32 ± 3.57), symptom frequency (6.29 ± 1.49 vs. 8.82 ± 1.47), HADS (11.82 ± 2.57 vs. 16.29 ± 3.13), anxiety (3.21 ± 1.64 vs. 5.61 ± 1.77), and depression (8.61 ± 1.52 vs. 10.68 ± 1.81), showed that the difference between the two groups was statistically significant (P < 0.05). The sleep state of the intervention group was better than the control group at T3, with decreased score of PSQI [4.00 (3.00,8.00) vs. 9.00 (7.00,12.50), Z = -3.706, P < 0.001].
UNASSIGNED: The 6-week REBT program can effectively improve the symptom, anxiety, depression, and sleep state of patients with CRC undergoing chemotherapy, which could as a care plan for patients with CRC who are repeatedly admitted to the hospital for chemotherapy.